%PDF-1.3
%
3 0 obj
<>>>/BBox[0 0 612 792]/Length 53>>stream
xs
w3T0WI2P0T5T R
Ɩf
!\!Y\ !p
o
endstream
endobj
1 0 obj
<>>>/BBox[0 0 612 792]/Length 53>>stream
xs
w3T0WI2P0T5T R
Ɩf
!\!Y\ !p
o
endstream
endobj
4 0 obj
<>>>/BBox[0 0 612 792]/Length 53>>stream
xs
w3T0WI2P0T5T R
Ɩf
!\!Y\ !p
o
endstream
endobj
7 0 obj
<>>>/BBox[0 0 612 792]/Length 53>>stream
xs
w3T0WI2P0T5T R
Ɩf
!\!Y\ !p
o
endstream
endobj
5 0 obj
<>>>/BBox[0 0 612 792]/Length 53>>stream
xs
w3T0WI2P0T5T R
Ɩf
!\!Y\ !p
o
endstream
endobj
6 0 obj
<>>>/BBox[0 0 612 792]/Length 53>>stream
xs
w3T0WI2P0T5T R
Ɩf
!\!Y\ !p
o
endstream
endobj
9 0 obj
<>stream
Acrobat Distiller 8.1.0 (Windows); modified using iText 4.2.0 by 1T3XT
Arbortext Advanced Print Publisher 9.0.114/W
2019-05-07T04:33:36-07:00
2019-04-19T05:21:29+05:30
application/pdf
LRB-2019-0024-ver9-Quere_2P 135..140
uuid:2f1991b7-21cd-4303-bf37-b1653cfed94b
uuid:105139d0-6642-4825-9a7e-0d4692d4b5fe
endstream
endobj
10 0 obj
<>stream
x+ |
endstream
endobj
11 0 obj
<>stream
xS**T0T0 Bi yJ%
endstream
endobj
12 0 obj
<>stream
x+ |
endstream
endobj
13 0 obj
<>stream
xS**T0T0 Bi ye(
endstream
endobj
14 0 obj
<>stream
x+ |
endstream
endobj
15 0 obj
<>stream
xS**T0T0 Bi yS&
endstream
endobj
16 0 obj
<>stream
x+ |
endstream
endobj
17 0 obj
<>stream
xS**T0T0 Bi y8#
endstream
endobj
18 0 obj
<>stream
x+ |
endstream
endobj
19 0 obj
<>stream
xS**T0T0 Bi yA$
endstream
endobj
20 0 obj
<>stream
x+ |
endstream
endobj
21 0 obj
<>stream
xS**T0T0 Bi y\'
endstream
endobj
23 0 obj
<>stream
/GS1 gs
BT
/F3 1 Tf
8.9663 0 0 8.9663 62.022 725.7825 Tm
0 0 0 rg
0 Tc
0 Tw
(Background)Tj
/F6 1 Tf
26.1167 0 0 26.1167 62.022 693.014 Tm
(E)Tj
/F8 1 Tf
9.843 0 0 9.843 80.3905 703.8423 Tm
[(pidemiology)-336.3(studies)-331(in)]TJ
/F5 1 Tf
10.5518 0 TD
[(lymphedema)-333.9(have)-335(frequently)]TJ
-10.5518 -1.1116 TD
[(focused)-246(on)-238.3(single)-244(patient)-246.6(populations)-243.9(such)-241.5(as)-245.1(those)-242.8(with)]TJ
-1.8661 -1.1116 TD
[(cancer)-230.1(rather)-222.1(than)-224.6(on)-221.1(assessing)-230.5(the)-223.5(heterogeneous)-226.2(population)]TJ
0 -1.1174 TD
[(that)-195.9(may)-195.8(suffer)-197.5(with)-201.4(the)-194.7(condition.)]TJ
7.3823 0 0 6.5614 195.9307 675.3825 Tm
(1)Tj
9.843 0 0 9.843 201.5432 670.9604 Tm
[(A)-197.8(public)-192.3(health)-199.3(denition)]TJ
-14.1746 -1.1116 TD
[(of)-215.3(chronic)-211.7(edema)-217.6(\(CO\))-213.6(has)-211.6(been)-214.1(devel)-8(oped)-212.9(and)-211.8(used)-212.7(over)-212.9(the)]TJ
T*
[(last)-276.3(decades)-282.9(and)-275.2(this)-280.9(reects)-281.6(the)-275.3(complex)-282.1(pattern)-275.2(of)-278.6(patients)]TJ
0 -1.1174 TD
[(who)-326.7(may)-328.2(present)-332.5(with)-328.1(the)-327.1(problem.)]TJ
7.3823 0 0 6.5614 205.5684 642.5006 Tm
(2)Tj
9.843 0 0 9.843 212.485 638.0786 Tm
[(The)-328.2(denition)-328.1(dened)]TJ
-15.2863 -1.1116 TD
[(below)-284.1(has)-280.7(been)-283.2(adopted)-280.9(in)-278.8(the)-281.1(LIMPRINT)-284.5(study:)]TJ
1.2153 -2.2232 TD
[()50.8(Chronic)-241.5(edema)-240.6(\(CO\))-242.4(is)-238.3(a)-238.4(broad)-237(term)-243(used)-235.8(to)-238.5(describe)]TJ
0 -1.1174 TD
[(edema)-188.8(that)-190.1(has)-188.6(been)-191(present)-188.5(for)-187.5(more)-191.1(than)-184.2(three)-192.2(months)]TJ
0 -1.1116 TD
[(and)-211.8(involves)-211.6(one)-211.8(or)-209.5(more)-214.1(of)-209.5(the)-211.9(following)-212.7(areas:)-211.6(limbs,)]TJ
T*
[(hands/feet,)-496(upper)-490.5(body)-494(\(breast/chest)-497(wall,)-493.9(shoulder,)]TJ
0 -1.1174 TD
[(and)-211.8(back\),)-212.8(lower)-215(body)-211.8(\(buttocks)-212.7(and)-211.8(abdomen\),)-211.6(genital)]TJ
0 -1.1116 TD
[(\(scrotum,)-285.2(penis,)-280.7(and)-280.9(vulva\),)-282(head,)-280.9(neck,)-280.9(or)-284.4(face.)51()]TJ
-.2016 -2.229 TD
[(The)-454.9(ter)12.7(m)-463.1(o)0(f)-457.2(C)0(O)-459.1(inc)12.7(lud)13.8(es)-458.2(tho)13.8(se)-458.2(wit)12.8(h)-461.9(bot)13.8(h)-461.9(pri)13.9(mar)11.6(y)-461.9(and)]TJ
-1.0137 -1.1116 TD
[(sec)11.8(ond)14(ary)-177.2(for)14(ms)-187.5(of)-186.5(lym)18.4(phe)12.8(dem)11.6(a,)-184.2(in)-186.6(add)12.8(iti)19.4(on)-186.5(to)-186.6(ven)12.8(ous)-175.9(ede)11.7(ma)]TJ
T*
[(and)-292.4(oth)13.8(er)-302.8(fac)11.7(to)15(rs)-301.5(suc)13(h)-300.6(a)0(s)-302.7(imm)17.2(obi)13.8(lit)13.6(y,)-298.3(adv)12.8(anc)11.7(ed)-297.1(can)11.7(cer)11.7(,)-302.9(obe)12.8(-)]TJ
T*
[(sit)13.9(y,)-338.6(and)-332.8(ca)12.8(rdi)13.9(ac)-338.6(and)-332.8(res)13(pir)13.9(ato)12.7(ry)-336.2(ins)14(uf)14.2(cie)11.5(ncy)12.8(.)-337.5(Wit)11.5(hin)-331.7(inp)13.8(a-)]TJ
0 -1.1174 TD
[(tie)12.6(nt)-278.8(ser)13(vic)12.7(es,)-277.3(man)11.6(y)-283.3(pat)12.7(ien)12.7(ts)-278.6(are)-276.3(eld)12.7(erl)12.7(y)-283.3(and)-275.2(wil)12.8(l)-289.2(suf)14.2(fer)-275.1(fro)14(m)]TJ
0 -1.1116 TD
[(mul)12.6(tip)13.7(le)-400.9(com)17.4(orb)14(idi)13.7(tie)12.6(s,)-401.8(for)-394.9(whi)13(ch)-400.8(the)18.4(y)-410(a)0(r)14(e)-405.4(rec)11.7(eiv)12.7(ing)-395.1(man)11.6(y)]TJ
T*
[(dif)13.9(fer)12.9(ent)-263.8(med)11.6(ica)11.5(tio)13.7(ns)-266.9(tha)12.7(t)-277.7(may)-264.9(als)12.9(o)-277.6(pro)14(mo)13.8(te)-274.2(CO.)]TJ
1.0137 -1.1174 TD
[(The)-403.1(general)-408.7(population)-404.2(is)-399.5(rapidly)-406.5(aging)-404.2(with)-403(increasing)]TJ
-1.0137 -1.1116 TD
[(comorbidities)-548.1(such)-541(as)-544.6(diabetes,)-545.7(immobility,)-541.7(and)-540.1(obesity,)]TJ
T*
[(which)-192(will)-190(further)-193.2(challenge)-193.4(health)-193.5(services)-196.3(in)-186.6(all)-194.8(countries)-190.8(of)]TJ
0 -1.1174 TD
[(the)-379(world.)]TJ
7.3823 0 0 6.5614 103.2944 423.3259 Tm
(3)Tj
9.843 0 0 9.843 110.6645 418.9038 Tm
[(This)-379.9(will)-380(lead)-375.5(to)-376.7(increasing)-383.2(numbers)-378.5(of)-376.5(hospi-)]TJ
-4.9418 -1.1116 TD
[(talized)-420.5(patients)-426(who)-418.9(are)-420.3(dened)-423.5(as)-417.9(frail)-421.6(with)-420.2(reduced)-420.1(life)]TJ
T*
[(expectancy.)-193.2(The)-195.7(concept)-189.9(that)-190.1(CO)-194.2(may)-190(be)-187.7(a)-192.3(predictor)-191(of)-192.2(frailty)]TJ
0 -1.1174 TD
[(as)-308.4(well)-312(as)-308.4(being)-312.1(a)-307.5(risk)-309.6(factor)-314.3(for)-308.5(complications)-313.1(such)-310.6(as)-308.4(cel-)]TJ
0 -1.1116 TD
[(lulitis)-284.6(and)-280.9(wounds)-278(is)-284.4(worthy)-278.3(of)-284.4(further)-279.6(investigation.)]TJ
1.0137 -1.1116 TD
-.0159 Tc
[(De)6.2(n).3(ing)-443.2(m)4.8(oderat)5.9(e)-444.4(and)-437.5(s).5(ever)6.1(e)-444.4(frai)5.9(lty)-443.2(is)-437.3(particularly)-437.5(chal-)]TJ
-1.0137 -1.1116 TD
-.0162 Tc
[(lengi)5.6(ng)-449.3(due)-450.4(t)5.6(o)-449.3(lack)-443.5(of)-449.2(agreed)-449.3(deniti)5.6(ons.)]TJ
7.3823 0 0 6.5614 229.4361 357.5621 Tm
0 Tc
(4)Tj
9.843 0 0 9.843 237.3732 353.1967 Tm
-.0156 Tc
[(Re)5.2(cent)-448.8(N)-.3(a)5.2(tional)]TJ
-17.8148 -1.1174 TD
-.0161 Tc
[(Institu)5.8(te)-329.4(for)-322.4(Health)-322.5(Care)-329.4(and)-328.2(E)-1.1(xcellence)-323.6(\().1(NICE\))-322.4(guidan)5.8(c)-1.1(e)-329.4(o).1(n)]TJ
0 -1.1116 TD
-.0163 Tc
[(mult)5.5(iple)-323.8(morbidities)-322.5(h)-.1(as)-322.5(hi)5.5(ghlighted)-322.7(the)-318.1(n)-.1(eed)-322.7(to)-316.9(develo)5.6(p)-322.7(n)-.1(ew)]TJ
T*
-.0161 Tc
[(robust)-282.3(e)-1.1(qu)5.8(ations)-281.9(to)-282.1(identify)-282.1(p).1(at)5.7(ients)-281.9(i)0(n)-282.1(primary)-282.1(c)-1.1(are)-289.1(o).1(r)-282.1(i)0(n)-282.1(hos-)]TJ
0 -1.1174 TD
-.0158 Tc
[(pital)-264.7(w)5.3(ith)-264.6(reduc)5(ed)-264.6(life)-265.7(e)-.8(x)6.1(p).4(ectanc)5(y)-264.6(so)-264.6(that)-264.7(rel)6(e)-.8(vant)-264.7(asse)5(ssments)]TJ
0 -1.1116 TD
-.0161 Tc
[(and)-650.8(i)0(nter)5.9(ventions)-650.6(can)-650.8(be)-651.9(targeted)-650.8(a)-1.1(ppropri)5.7(ately.)-653.1(Existing)]TJ
T*
-.0163 Tc
[(equat)5.5(i)-.2(ons)-270.6(to)-265.1(predict)-271(risk)-270.8(o)5.6(f)-270.8(death)-265.1(a)-1.3(re)-266.2(based)-270.8(o)5.6(n)-270.8(b)-.1(iased)-270.8(s).1(ampl)5.5(e)-1.3(s,)]TJ
0 -1.1174 TD
-.0158 Tc
[(are)-340.6(i).3(nsufci)6(ently)-339.4(powered)6.1(,)-341.8(f).4(ail)-345.3(t)6(o)-345.2(h).4(an)6.1(dle)-346.4(m)4.9(issing)-339.4(data)-340.6(appro-)]TJ
0 -1.1116 TD
-.0161 Tc
[(priately,)-307.5(are)-306.3(poo)5.8(rly)-310.9(r)5.9(eported,)-301.8(o).1(r)-305.1(h).1(ave)-306.3(poor)-305.1(performance)-306.3(to)-305.2(the)]TJ
T*
[(exten)5.9(t)-345.5(that)-345.5(NICE)-346.6(has)-339.4(b).2(een)-345.4(unable)-346.6(t).1(o)-345.4(m)4.7(ake)-346.6(a)-346.6(p)5.9(ositive)-346.6(r)6(ecom-)]TJ
T*
[(mend)5.8(a)-1.1(tion)-380.1(o)5.8(n)-380.1(a)-1.1(ny)-380.1(t)5.7(ool.)-376.6(T)-1.1(he)-381.2(availabil)5.7(ity)-380.1(of)-380(su)5.8(ch)-380.1(tool)5.7(s)-379.9(w)-.8(ould)]TJ
0 -1.1174 TD
-.0159 Tc
[(allow)-444.1(for)-443.2(the)-444.4(i).2(den)6(ticatio)6(n)-449(o).3(f)-443.2(p).3(ati)5.9(e)-.9(nts)-443(a)-.9(t)-449.1(r)6.1(isk)-449(o)6(f)-448.9(unp)6(lanned)]TJ
0 -1.1116 TD
-.0163 Tc
[(hospit)5.5(a)-1.3(l)-282.5(a)-1.3(dmissions)-276.4(or)-282.3(impending)-276.6(deat)5.5(h.)]TJ
1.0137 -1.1116 TD
0 Tc
[(Although)-407.4(recent)-407.6(guidance)-404.1(from)-408.7(NICE)-404.9(on)-405.4(multiple)-403.4(mor-)]TJ
-1.0137 -1.1174 TD
[(bidities)-286.8(has)-286.5(recommended)-289.9(tools)-287.8(to)-284.5(predict)-286.7(risk)-286.5(of)-284.4(unplanned)]TJ
0 -1.1116 TD
[(hospital)-315.4(admissions,)-310.3(they)-311(were)-312.8(unable)-314.3(to)-307.6(identify)-309.8(any)-315.5(equa-)]TJ
T*
[(tion)-189(to)-180.9(reliably)-190(predict)-188.8(all-cause)-187.4(mortality.)-189(A)-186.3(recent)-188.7(review)-188.4(by)]TJ
0 -1.1174 TD
[(NICE)-220.6(of)-215.3(41)-215.3(studies)-221.9(to)-215.4(predict)-217.6(all-cause)-221.9(mortality)-220.1(found)-218.6(many)]TJ
0 -1.1116 TD
[(methodological)-435.4(limitations,)-433.2(including)-426.2(the)-430.8(omission)-430.4(of)-428.4(key)]TJ
T*
[(determinants)-317.6(of)-318.9(death,)-316.7(such)-316.4(as)-314.2(age)-316.7(and)-315.5(sex.)-313(In)-318.9(addition,)-313.3(the)]TJ
0 -1.1174 TD
[(sample)-338.4(sizes)-335.9(were)-335.9(frequently)-336.1(small)-336.3(and)-332.8(unrepresentative)-340.4(of)]TJ
0 -1.1116 TD
[(the)-281.1(population.)]TJ
7.3823 0 0 6.5614 121.6062 127.3889 Tm
(5)Tj
9.843 0 0 9.843 72 112.0819 Tm
.0189 Tc
[(Lymp)-5.2(hed)-5.2(e)-.6(ma)-346.2(ma)-6.4(nage)-6.4(ment)-350.9(is)-344.9(f)-5.2(r).6(eq)-5.2(uen)-5.2(tly)-350.8(unde)-6.4(rta)-6.4(k).5(en)-345.1(i)-5.4(n)]TJ
-1.0137 -1.1116 TD
-.0217 Tc
[(an)-230.1(ou)-5.5(tp)-5.5(ati)-5.6(e)-.9(nt)-230.3(se)-6.7(tti)-5.6(ng,)-232.5(exc)-6.7(e)-.9(pt)-230.3(fo)-5.5(r)-230.1(d)]TJ
12.7232 0 TD
-.0204 Tc
[(edica)-5.4(t)1.4(ed)-228.8(specialist)-229(c).4(e)-5.4(n)1.5(te)-5.4(rs)-228.6(tha)-5.4(t)]TJ
-12.7232 -1.1174 TD
-.0216 Tc
[(ch)-5.4(oos)-5.2(e)-173.6(t).2(o)-178.2(a)-.8(dmi)-5.5(t)-172.6(pe)-6.6(opl)-5.5(e)-173.6(f).4(o)-5.4(r)-172.4(int)-5.5(e)-.8(ns)-5.2(iv)-5.4(e)-173.6(p).3(er)-5.4(io)-5.4(ds)-172.3(o)-5.4(f)-172.4(tr)-5.4(eatm)-6.6(e)-.8(nt)-178.3(\(CD)-6.3(T)-.8(\).)]TJ
0 -1.1116 TD
-.0201 Tc
[(There)-339.1(i)1.7(s)-332(l)-4(ittle)-333.4(a)-5.1(w)1(arene)-5.1(s)2(s)-332(o)-3.9(f)-332.2(h)1.8(ow)-333.1(many)-332.2(pa)-5.1(tie)-5.1(nts)-337.8(m).6(ay)-332.2(have)-333.4(C)-4.9(O)]TJ
T*
-.0216 Tc
[(wi)-5.5(th)-5.4(in)-385.6(i)-5.5(npa)-6.6(ti)-5.5(ent)-391.4(s).5(e)-6.6(r).4(vi)-5.5(ces)-5.2(.)-387.9(I).4(t)-391.4(i).2(s)-391.1(lik)-5.4(el)-5.5(y)-385.6(t).2(h)-5.4(a)-.8(t)-391.4(C)-.7(O)-386.4(w)-6.3(ill)-391.4(no)-5.4(t)-385.7(b)-5.4(e)-386.7(t).2(h)-5.4(e)]TJ
0 -1.1174 TD
-.0154 Tc
[(p)6.5(r).8(i)6.4(m)5.3(ar)6.6(y)-269.9(r)6.6(ea)5.4(s)6.7(o).8(n)-269.9(f)6.6(o)6.5(r)-269.9(ad)6.5(m)5.3(i).7(s)6.7(s)1(i)6.4(o)6.5(n)-269.9(a)5.4(nd)-269.9(t)6.4(h)6.5(at)-270.1(s)6.7(w)5.7(el)6.4(l)6.4(i).7(n)6.5(g)-269.9(m)5.3(a)-.4(y)-264.2(b).8(e)-271.1(l)6.4(a)5.4(r).8(g)6.5(e)5.4(ly)]TJ
25.504 67.8551 TD
-.0216 Tc
[(i)-5.5(g).3(n)-5.4(o).3(re)-6.6(d)-184(a)-6.6(s)-183.8(p)-5.4(ure)-6.6(l).2(y)-189.7(a)-185.1(s)-5.2(y).3(mp)-5.4(tom)-191(o).3(f)-189.7(a)-185.1(r)-5.4(e)-.8(l)-5.5(a)-.8(te)-6.6(d)-184(m)-.9(e)-6.6(d).3(ic)-6.6(al)-189.9(con)-5.4(d).3(it)-5.6(ion)-189.7(s)-5.2(uch)]TJ
0 -1.1174 TD
-.0204 Tc
[(a)-5.4(s)-269(ca)-5.4(rdiac,)-271.5(rena)-5.4(l)-269.3(d)1.5(isea)-5.4(se)-5.4(,)-265.7(o)-4.2(r)-269.1(d)1.5(e)-5.4(e).4(p)-269.2(v)-4.2(ein)-269.2(t)-4.3(hrombosis.)]TJ
1.0137 -1.1116 TD
0 Tc
[(The)-449.2(methodology)-446.8(developed)-451.3(within)-445.6(the)-448.1(LIMPRINT)-445.8(in-)]TJ
-1.0137 -1.1116 TD
[(ternational)-494.2(epidemiology)-495.2(included)-489.5(methods)-493.9(to)-491.9(be)-487.2(able)-490.7(to)]TJ
T*
[(screen)-361.2(large)-353.5(numbers)-355.5(of)-353.5(patients)-351.2(within)-359.2(a)-353.6(hospital)-350(settin)-8(g.)]TJ
7.3823 0 0 6.5614 548.5038 685.7006 Tm
(6)Tj
9.843 0 0 9.843 313.0582 670.3369 Tm
[(Hospit)-7.6(al)-268.4(inpatient)-266.2(studies)-273.7(are)-270.5(urgently)-269.4(required)-270.4(to)-267.3(determine)]TJ
T*
[(the)-298.3(number)-297(of)-290.1(people)-297.1(with)-293.5(CO)-297.8(and)-292.5(its)-291.3(impact)-298.4(on)-295.9(health)-291.4(ser-)]TJ
T*
[(vices.)-385.6(There)-383.4(is)-382.3(increasing)-383.2(awareness)-383.6(that)-380.2(CO)-384.2(is)-382.3(associated)]TJ
0 -1.1174 TD
[(with)-333.8(major)-330.5(complications)-336.2(such)-327.9(as)-331.5(cellulitis,)-334.1(which)-330.2(have)-329.3(as-)]TJ
0 -1.1116 TD
[(sociated)-294.6(mortality)-289.3(as)-291.2(well)-288.9(as)-285.4(being)-289(a)-290.2(drain)-289(on)-284.4(health)-291.4(service)]TJ
T*
(resources.)Tj
1.0137 -1.1174 TD
[(Cross-sectional)-464.3(based)-456.9(prevalence)-460.4(studies)-452.2(can)-460.6(be)-452.6(under-)]TJ
-1.0137 -1.1116 TD
[(taken)-249.9(in)-244.2(dened)-244.9(health)-251.1(care)-244(settings)-251.9(such)-241.5(as)-250.8(hospitals)-247.2(or)-244.1(care)]TJ
T*
[(homes)-226.6(where)-221.8(the)-223.5(population)-219.9(is)-221(xed)-224.3(over)-224.4(a)-221.1(short)-218.5(time)-225.9(period.)]TJ
T*
[(In)-215.3(these)-215.1(settings,)-215(a)-209.6(visiting)-216.5(team)-209.7(of)-215.3(researchers)-219(can)-213(determine)]TJ
0 -1.1174 TD
[(the)-453.8(number)-446.7(of)-445.7(people)-452.6(and)-448(clinically)-452.9(assess)-451.7(them,)-448.1(thereby)]TJ
0 -1.1116 TD
[(deriving)-471(an)-469.9(accurate)-475.5(estimation)-475.7(of)-468.7(the)-465.4(prevalence)-477.7(in)-468.9(that)]TJ
T*
[(settin)-8(g)-277.6(a)0(t)-280(a)-284.5(given)-277.5(time)-283.5(point.)]TJ
1.0137 -1.1174 TD
-.0156 Tc
[(Ai)-15.6(m)9.6(:)-293.3(To)-293.2(es)-15.6(t)11.1(i).5(mat)-15.6(e)-284(a)-294.3(poi)-15.6(n)10.9(t)-293.3(pr)-15.6(e)9.9(v).6(ale)-15.6(n)9.8(ce)-294.3(of)-298.9(CO)-294(and)-293.2(w)-15.6(o)10.1(und)-15.6(s)-282.6(a)-.6(s)]TJ
-1.0137 -1.1116 TD
-.0158 Tc
[(p)-15.8(r)10.8(evi)-15.8(o)10.7(usl)-15.8(y)-415.5(de)-15.8(n)11(ed)-425.8(in)-431.6(inpa)-15.8(t)9.5(i).3(en)-15.8(t)10.7(s)-425.6(ad)-15.8(m)9.6(i).3(tted)-431.6(in)-425.8(ho)-15.8(s)11(p).4(it)-15.8(a)9.5(l)-426(in)-431.6(ve)]TJ
T*
0 Tc
[(di)26.5(f)16.2(f)0(e)25.5(r)16.2(e)15(n)16.2(t)-191.3(c)0(o)25.4(u)16.2(n)16.2(t)16(ri)26.5(e)15(s)-191(w)15.3(i)0(t)26.3(h)16.2(i)16.1(n)-191.2(th)26.5(e)-192.3(L)15(I)16.2(M)15.3(PR)25.7(I)16.2(N)15.3(T)-192.4(I)0(n)26.6(t)16(e)15(r)16.2(na)25.4(t)16(i)16.1(on)26.6(a)15(l)-191.3(P)16.4(r)0(o)26.6(j)16.1(e)15(c)15(t)0(.)]TJ
/F9 1 Tf
8.9663 0 0 8.9663 313.0582 484.0439 Tm
(Methodology)Tj
/F5 1 Tf
9.843 0 0 9.843 323.0361 467.603 Tm
[(The)-374.3(acronym)-379.9(LIMPRINT)-376.7(stands)-376.1(for)-377.6(Lymphoedema)-376.4(IM-)]TJ
-1.0137 -1.1174 TD
[(pact)-248.8(and)-246.4(PRevalence-)-249.3(INTernational.)-254(The)-247.6(overall)-246.4(aim)-242(was)-247(to)]TJ
0 -1.1116 TD
[(determine,)-427.2(using)-420.1(a)-417(common)-424.9(methodology,)-421.4(the)-419.3(impact)-425.1(and)]TJ
T*
[(prevalence)-408.6(of)-399.6(CO)-401.5(within)-405.3(health)-400.8(services)-403.7(at)-400.9(a)-405.4(national)-403.2(and)]TJ
T*
[(internation)-9.2(al)-262.7(level.)-265(This)-264.7(study)-258.9(was)-264.3(undertaken)-268(as)-262.4(part)-264.9(of)-267.1(this)]TJ
0 -1.1174 TD
[(internation)-9.2(al)-187.8(project.)-198(Specic)-195.3(methodological)-193.5(issues)-191.6(required)]TJ
0 -1.1116 TD
[(to)-284.6(undertake)-284.2(this)-280.9(study)-281.9(are)-282.1(dened)-279.5(below.)]TJ
/F9 1 Tf
8.9663 0 0 8.9663 313.0582 379.8991 Tm
[(Patient)-337.7(inclusion)-336.4(and)-329.4(exclusion)-339(criteria)]TJ
/F5 1 Tf
9.843 0 0 9.843 323.0361 363.4582 Tm
[(The)-518.3(study)-518.1(patient)-517.3(inclusion)-518.1(criterion)-519.4(was)-517.8(swelling)-517.9(for)]TJ
-1.0137 -1.1116 TD
[(longer)-376.5(than)-380.1(3)-375.5(months)-376.4(\(CO\),)-372.5(with)-379.9(explicit)-374.5(consent)-378.6(for)-377.6(their)]TJ
0 -1.1174 TD
[(data)-260.3(to)-261.5(be)-256.8(transferred)-263.1(into)-258.1(an)-256.8(international)-266.1(database.)-258.7(Patients)]TJ
0 -1.1116 TD
[(met)-409(exclusion)-409.7(criteria)-410(if)-405.5(they)-408.9(were)-410.8(unwilling)-408.7(or)-405.4(unable)-406.5(to)]TJ
T*
[(participate)-259.2(for)-256.7(whatever)-255.2(reason)-256.4(or)-249.8(were)-261(receiving)-255.5(end-of-life)]TJ
T*
(care.)Tj
/F3 1 Tf
8.9663 0 0 8.9663 313.0582 286.7527 Tm
(Methods)Tj
/F5 1 Tf
9.843 0 0 9.843 323.0361 270.3117 Tm
[(Sampling)-224.4(frameworks)-222.5(were)-226.4(developed)-220.9(for)-222.1(all)-217.8(participating)]TJ
-1.0137 -1.1174 TD
[(inpatient)-346.8(hospitals)-339.4(within)-341.9(the)-338.7(study.)-337.2(The)-339.7(screening)-341.6(was)-339.2(un-)]TJ
0 -1.1116 TD
[(dertaken)-329.2(in)-319.1(a)-319(single)-324.6(day)-321.2(or)-319(over)-322.3(a)-319(number)-325.8(of)-319(days)-322.2(in)-319.1(larger)]TJ
T*
[(facilities.)-196.9(Trained)-189.9(staff)-190.8(screened)-197.5(all)-189(patients)-189.9(who)-188.5(consented)-191.9(to)]TJ
0 -1.1174 TD
[(participate,)-326(irrespective)-323.3(of)-318.9(their)-323.7(underlying)-317.7(disease)-322(or)-318.9(treat-)]TJ
0 -1.1116 TD
[(ment)-346.8(regimen.)-343.1(The)-345.5(presence)-347.3(and)-344.3(chronicity)-342(of)-347.8(edema)-344.3(were)]TJ
T*
[(conrmed)-490.2(by)-486(two)-488.1(methods)-488.1(before)-486.9(CO)-487.9(was)-489(judged)-486(to)-486.1(be)]TJ
0 -1.1174 TD
[(present)-286.4(\(a)-279.8(case\).)]TJ
/F10 1 Tf
1.0137 -1.1116 TD
[(Conrmation)-307.8(of)-307.6(CO)]TJ
/F5 1 Tf
8.4207 0 TD
[(was)-310.4(based)-307.1(on)-307.5(the)-304.1(following)-310.6(two)-309.6(fac-)]TJ
-9.4344 -1.1116 TD
[(tors:)-316.6(rst,)-312.8(the)-315.6(existence)-314.1(of)-313.2(edema)-315.5(was)-316.2(determined)-315.5(using)-316.5(the)]TJ
T*
[()45(Pitting)-521.7(Edema)-528.6(Test,)52.2()-525.2(which)-526(is)-520.5(widely)-527.3(used)-523.7(in)-520.7(clinical)]TJ
0 -1.1174 TD
[(practice)-198(and)-194.5(been)-196.8(shown)-190.5(to)-192.4(be)-193.4(valid)-197(and)-194.5(reliable.)]TJ
7.3823 0 0 6.5614 501.4487 154.0913 Tm
(7)Tj
9.843 0 0 9.843 507.0046 149.726 Tm
[(Presence)-197.4(of)]TJ
-19.704 -1.1116 TD
[(edem)-8(a)-215.4(was)-218.3(tested)-222.1(in)-215.4(all)-223.6(body)-217.5(parts,)-217.4(using)-218.6(a)-221.1(standard)-218.4(protocol,)]TJ
T*
[(including)-328.3(the)-321.4(upper)-323.4(and)-321.2(lower)-324.4(limbs,)-321.3(trunk,)-325.8(face,)-322.3(and)-321.2(neck.)]TJ
0 -1.1174 TD
[(Second,)-190.8(edema)-188.8(was)-183.7(judged)-186.4(to)-186.6(be)-181.9(chronic)-188.7(if)-186.6(it)-186.8(had)-183(been)-185.3(present)]TJ
0 -1.1116 TD
[(for)-285.5(3)-277.6(months)-284.2(or)-278.6(more.)]TJ
/F9 1 Tf
8.9663 0 0 8.9663 313.0582 83.9622 Tm
[(Classication)-291.2(of)-286.2(Primary)-282.9(and)-285.1(Secondary)-286.7(Lymphedema)]TJ
/F5 1 Tf
9.843 0 0 9.843 323.0361 67.5212 Tm
[(F)16.3(o)0(l)26.5(l)16(o)16.2(w)0(i)25.6(n)16.2(g)-346.7(t)16.1(he)-337.4(i)16.1(d)16.2(e)15(n)16.2(ti)26.3()16.3(c)15(at)25.3(i)16(o)16.2(n)-346.7(o)16.2(f)-352.4(a)15(l)16.1(l)-346.8(c)15(a)15(s)0(e)25.6(s)16.4(,)-349(a)-347.8(f)16.2(u)16.2(r)0(t)26.5(h)16.2(e)15(r)-346.6(cl)25.3(a)15(s)16.4(si)26.7()16.3(-)]TJ
-1.0137 -1.1116 TD
[(ca)24.3(t)16(i)16.1(on)-157.7(wa)24.6(s)-173.7(m)15(a)15(d)16.2(e)-175(o)16.2(f)-173.9(w)15.3(he)25.4(t)16.1(h)16.2(er)-158.8(th)26.5(e)-175(C)15.2(O)-174.8(w)15.3(a)15(s)-173.7(a)-175.1(p)16.2(ri)26.5(m)15(a)15(r)16.2(y)-173.9(o)16.2(r)-173.9(s)0(e)25.6(c)15(o)16.2(n)0(d)26.6(a)15(r)16.2(y)]TJ
/F3 1 Tf
8.9663 0 0 8.9663 62.022 749.6502 Tm
(136)Tj
47.5546 0 TD
(QUE)Tj
1.6692 .2087 TD
()Tj
.4995 -.2087 TD
(RE)Tj
.8852 .2087 TD
()Tj
.8283 -.2087 TD
[(ET)-338.7(AL.)]TJ
ET
endstream
endobj
35 0 obj
<>stream
/GS1 gs
BT
/F5 1 Tf
9.843 0 0 9.843 59.7543 405.581 Tm
0 0 0 rg
.0117 Tc
0 Tw
[(lymp)4.8(hed)4.8(e)-2.1(ma)-399.5(b)4.8(y)-398.3(sp)4.8(eciali)4.7(st)-398.5(l)4.7(y)-.9(mph)4.8(o)-.9(lo)4.8(gi)4.7(st)4.7(s.)-394.9(In)-398.3(t)4.7(h)-.9(o)4.8(s)-.7(e)-399.5(w)4(it)4.7(h)-398.3(a)]TJ
0 -1.1174 TD
.0118 Tc
[(secon)4.9(d)-.8(ary)-340.6(l)4.8(ymph)4.9(ed)4.9(ema,)-337.2(ad)4.9(di)4.8(ti)4.8(onal)-340.8(s)-.6(u)4.9(s)-.6(p)4.9(e)-2(cted)-340.6(fact)4.8(ors)-334.7(were)]TJ
0 -1.1116 TD
.0131 Tc
[(ch)6.2(ec)5.1(ked)6.2(,)-278.3(i)6.1(n).5(cl)6.1(ud)6.2(in)6.2(g)-281.7(v)6.2(en)6.2(ou)6.2(s)-281.5(d)6.2(is)6.4(ea)5.1(se)-277.1(an)6.2(d)-276(obe)5.1(si)6.1(ty)6.2(.)]TJ
/F9 1 Tf
8.9663 0 0 8.9663 59.7543 359.2062 Tm
0 Tc
[(Other)-333.7(data)-332.9(collection)]TJ
/F5 1 Tf
9.843 0 0 9.843 69.7323 342.7653 Tm
[(A)-266.9(body)-263.6(map)-270.6(was)-264.3(used)-270.3(to)-261.5(record)-268.1(the)-269.5(sites)-265.7(and)-269.4(causes)-268.9(of)-261.4(all)]TJ
-1.0137 -1.1116 TD
[(concurrent)-440.8(wounds)-7.3(.)-435.4(Lower)-440.7(and)-436.4(upper)-438.6(mobility)-436.8(status)-439.6(was)]TJ
T*
[(dened)-400.4(and)-396.1(information)-400.7(about)-392.7(the)-396.3(history)-399.4(of)-393.8(cellulitis)-399.8(and)]TJ
0 -1.1174 TD
[(treatment)-285.7(were)-284(also)-282(recorded.)]TJ
/F9 1 Tf
8.9663 0 0 8.9663 59.7543 285.5054 Tm
[(Quality)-337.7(systems)]TJ
/F5 1 Tf
9.843 0 0 9.843 69.7323 269.0645 Tm
.0119 Tc
[(A)-433.6(n)5(umber)-432.7(o)5(f)-432.7(q)-.7(u)5(a)-1.9(l)4.9(i)-.8(t)4.9(y)-432.7(sy)5(st)4.9(ems)-432.5(w)4.2(ere)-428.1(u)-.7(s)5.2(e)-1.9(d)-426.9(t)-.8(o)-432.7(e)3.9(ns)5.2(ur)5.1(e)-433.9(t)-.8(h)5(e)]TJ
-1.0137 -1.1174 TD
.0113 Tc
[(accu)4.4(racy)-266.3(o)4.4(f)-266.2(data)-261.7(capt)4.3(ure.)-262.8(T)-2.5(h)4.4(e)-267.4(b)4.4(e)-2.5(d)-260.5(c)-2.5(apacit)4.3(y)-266.3(o)4.4(f)-266.2(e)-2.5(ach)-260.5(w)-2.2(ard)-260.5(o)-1.3(r)]TJ
25.5097 47.4542 TD
.0116 Tc
[(u)4.7(n)-1(i)4.6(t)-358.3(was)-357.9(r)-1(eco)4.7(rded,)-354.7(pl)4.6(us)-357.9(t)4.6(h)-1(e)-353.5(n)-1(u)4.7(m)-2.2(b)4.7(e)-2.2(r)-358.1(o)4.7(f)-358.1(b)-1(eds)-357.9(o)4.7(ccup)4.7(ied,)-354.7(th)4.7(e)]TJ
0 -1.1174 TD
[(n)4.7(u)-1(mber)-386.9(r)4.8(e)-2.2(cru)4.7(i)-1.1(t)4.6(e)-2.2(d,)-377.7(an)4.7(d)-381.2(t)-1.1(he)-382.3(n)4.7(u)-1(mber)-381.1(ex)4.7(cl)4.6(uded)-381.1(f)-1(r)4.8(o)-1(m)-382.4(c)3.6(ons)4.9(id)4.7(-)]TJ
0 -1.1116 TD
.0118 Tc
[(eratio)4.9(n)-213.9(a)-2(n)4.9(d)-219.7(t)4.8(h)-.8(e)-215.1(r)-.8(eas)5.1(ons)-213.7(fo)4.9(r)-213.9(t)-.9(hi)]TJ
12.0435 0 TD
.0096 Tc
[(s.)-218.5(This)-221.7(enable)-4.2(d)-216.1(t)]TJ
6.6179 0 TD
.0095 Tc
[(he)-223.1(prevalenc)-4.3(e)]TJ
-18.6614 -1.1116 TD
[(to)-435.1(be)-436.3(ca)-4.3(lc)-4.3(ulate)-4.3(d)-435.1(ac)-4.3(cura)-4.3(te)-4.3(ly)-435.1(in)-435.1(inpatie)-4.3(n)2.6(t)-435.2(h)-3.1(ospital)-435.2(s)-2.9(ettings.)]TJ
T*
.0072 Tc
[(Do)-5.4(ub)-5.4(l)-5.5(e)-352.2(co)-5.4(un)-5.4(t)-5.5(i).2(n)-5.4(g)-351(of)-356.7(pa)-6.6(ti)-5.5(e)-6.6(n).3(t)-5.5(s)-350.8(w)-6.3(h).3(o)-351(m)-6.6(ay)-351(h)-5.4(a)-6.6(ve)-352.2(m)-6.6(o).3(v)-5.4(e)-.8(d)-356.8(w)-.5(i)-5.5(t).2(h)-5.4(i).2(n)]TJ
0 -1.1174 TD
.0115 Tc
[(t)4.5(h)-1.1(e)-393.9(h)4.6(os)4.8(pit)4.5(a)-2.3(l)-387.1(a)-2.3(nd)-387(be)-393.9(r)4.7(e)-2.3(cru)4.6(ited)-392.8(t)4.5(wice)-393.9(was)-392.6(p)4.6(reven)4.6(t)-1.2(ed)-392.8(by)-387(th)4.6(e)]TJ
0 -1.1116 TD
.0072 Tc
[(al)-5.5(lo)-5.4(c)-6.6(a)-.8(t)-5.5(i).2(o)-5.4(n)-621.7(of)-621.7(a)-622.9(p).3(a)-6.6(t)-5.5(ie)-6.6(nt)-5.5(-s)-5.2(p)-5.4(e)-.8(c)-6.6(i).2()-5.3(c)-622.9(no)-5.4(ni)-5.5(de)-6.6(nt)-5.5(i)-5.5().5(a)-6.6(b).3(l)-5.6(e)-622.9(nu)-5.4(mb)-5.4(er)-5.4(.)]TJ
T*
[(Wi)-5.5(th)-5.4(in)-362.5(e)-6.6(a)-.8(c)-6.6(h)-356.8(f)-5.4(a)-6.6(ci)-5.5(li)-5.5(ty)-5.4(,)-359.1(q)-5.4(ua)-6.6(li)-5.5(t)-5.5(y)-356.8(m)-6.6(o).3(n)-5.4(i).2(t)-5.5(o)-5.4(rs)-362.3(w)-6.3(e)-.8(r)-5.4(e)-357.9(e)-6.6(s)-5.2(ta)-6.6(bl)-5.5(is)-5.2(h)-5.4(e)-.8(d)-362.5(t).2(o)]TJ
0 -1.1174 TD
.0119 Tc
[(check)-317.5(c)3.9(ompl)4.9(et)4.9(eness)-317.3(o)5(f)-317.5(d)-.7(ata)-318.7(f)5.1(ro)5(m)-318.7(e)-1.9(ach)-311.7(c)-1.9(li)4.9(ni)4.9(cal)-317.6(a)-1.9(r)5.1(e)-1.9(a)-318.7(b)5(ef)5.1(ore)]TJ
0 -1.1116 TD
.0133 Tc
[(t)6.3(h).7(e)-259.7(r)6.5(ese)5.3(a)-.5(r)6.5(c)-.5(h)-258.5(t)6.3(ea)5.3(ms)-258.3(l)6.3(e)-.5(f)6.5(t)-258.6(th)6.4(e)-259.7(a)-.5(r)6.5(e)-.5(a)-259.7(a)5.3(nd)-258.5(a)5.3(l).6(l)-258.6(f)6.5(or)6.5(ms)-258.3(w)5.6(e)-.5(r)6.5(e)-259.7(ch)6.4(ec)5.3(ke)5.3(d)]TJ
T*
[(b)6.3(y)-281.6(a)-277(c)5.2(en)6.3(tr)6.4(al)-276(co)6.3(or)6.4(di)6.2(nat)6.2(o).6(r)6.4(.)]TJ
/F9 1 Tf
8.9663 0 0 8.9663 310.8472 593.1778 Tm
0 Tc
[(Data)-331.3(analysis)]TJ
/F5 1 Tf
9.843 0 0 9.843 320.8251 576.7936 Tm
[(All)-298.2(information)-302.8(was)-298.9(entered)-305(into)-298.4(a)-301.8(bespoke)-297.8(database)-307.2(sys-)]TJ
-1.0137 -1.1174 TD
[(tem,)-303(which)-301.4(was)-304.6(then)-305.2(downloaded)-302.3(to)-301.8(the)-304.1(statistical)-309.7(packages)]TJ
0 -1.1116 TD
[(being)-254.5(used)-253(\(SAS,)-256(Stata)-255.6(12.0\).)-253.2(Data)-255.4(quality)-256.9(checks)-257.6(were)-255.2(used)]TJ
T*
[(to)-359.4(check)-360.3(the)-361.7(internal)-357.1(consistency)-366.8(of)-359.3(the)-355.9(data.)-361.6(The)-362.8(determi-)]TJ
0 -1.1174 TD
[(nation)-411.2(of)-411.1(prevalence)-414.4(was)-414.1(undertaken)-412(by)-411.1(dividing)-406.6(the)-413.5(case)]TJ
0 -1.1116 TD
[(positives)-345.1(by)-347.8(the)-344.4(total)-352.6(number)-343(of)-347.7(patients)-351.2(who)-344(had)-344.3(been)-352.3(as-)]TJ
T*
[(sessed.)-432.2(These)-435.1(were)-433.8(presented)-433.8(as)-429.4(percentages.)-436(Comparison)]TJ
0 -1.1174 TD
[(of)-399.6(risk)-401.7(factors)-407.3(between)-403.9(groups)-398(was)-402.6(undertaken)-406.3(using)-402.9(Chi-)]TJ
0 -1.1116 TD
[(squared)-280.5(analysis,)-285.2(with)-282(the)-281.1(results)-285.2(presented)-284(as)]TJ
/F10 1 Tf
18.8573 0 TD
(p)Tj
/F5 1 Tf
.7776 0 TD
(values.)Tj
/F3 1 Tf
8.9663 0 0 8.9663 310.8472 466.7527 Tm
(Results)Tj
/F5 1 Tf
9.843 0 0 9.843 320.8251 450.3117 Tm
[(The)-264.9(LIMPRINT)-267.2(study)-264.6(was)-264.3(undertaken)-268(within)-267.1(seven)-266.8(acute)]TJ
-1.0137 -1.1116 TD
[(health)-239.6(care)-238.2(facilities)-239.5(in)-238.5(ve)-240.4(countries.)-240.3(The)-236(different)-242.8(hospitals)]TJ
0 -1.1174 TD
[(participating)-485(in)-474.6(the)-482.7(study)-477.7(were)-485.6(two)-476.6(teaching)-484.9(hospitals)-483.4(in)]TJ
0 -1.1116 TD
[(Nottingham)-314.2(\(Queens)-311.3(Medical)-311.9(Centre)-315.3([QMC]\),)-312.3(Nottingham)]TJ
T*
[(City)-305.2(Hospital)-316.3(\(City\),)-305(United)-314.2(Kingdom;)-304.9(four)-309.6(teaching)-312.1(hospi-)]TJ
0 -1.1174 TD
[(tals)-270.6(Saint)-266(Eloi,)-274.2(Gui)-269.3(de)-268.3(Chauliac,)-270.5(Lapeyronie,)-272.7(and)-269.4(Arnaud)-273.6(de)]TJ
0 -1.1116 TD
[(Villeneuve)-539.9(in)-538(Montpellier,)-543.4(France;)-541(two)-534.2(hospitals)-541(in)-538(Co-)]TJ
T*
[(penhagen,)-413.2(Denmark)-415.3(\(Bispebjerg)-418.7(and)-413.4(Frederiksberg)-414.9(Hospi-)]TJ
0 -1.1174 TD
[(tal\);)-456.3(one)-453.7(general)-460.6(hospital)-459.4(in)-451.6(Canberra,)-460.2(Australia)-462.5(\(Calvary)]TJ
0 -1.1116 TD
[(Public)-301.6(Hospital)-299(Bruce\);)-304.9(and)-298.2(one)-304(inpatient)-300.7(oncology)-298.1(ward)-305.9(in)]TJ
T*
[(Galway,)-285(Ireland)-280.8(\(University)-285(Hospital)-281.7(Galway\).)]TJ
/F9 1 Tf
8.9663 0 0 8.9663 310.8472 318.3873 Tm
[(Proportion)-334.6(of)-330.4(patients)-337.4(in)-330.2(hospital)-337.2(within)-337.9(the)-334.8(whole)]TJ
0 -1.2267 TD
[(population)-331.9(of)-336.7(the)-334.8(study)]TJ
/F5 1 Tf
9.843 0 0 9.843 320.8251 290.948 Tm
[(A)-197.8(total)-202.9(of)-203.8(1905)-200.2(patients)-207.2(were)-203.4(included)-207.2(and)-200.3(assessed)-207.4(for)-204.8(CO)]TJ
-1.0137 -1.1116 TD
[(and)-252.1(wounds)-249.2(from)-253.2(a)-249.9(total)-254.7(of)-249.8(3041)-252.1(eligible)-253.6(hospital)-252.1(occup)-7.8(ants.)]TJ
T*
[(In)-238.3(two)-234.7(of)-238.3(the)-240.7(hospitals)-241.5(patients)-236(who)-240.3(were)-238(assesse)-10.4(d)-237.2(and)-234.8(found)]TJ
0 -1.1174 TD
[(no)20.8(t)-485(t)0(o)-480.4(h)0(a)19.7(v)0(e)-481.4(C)0(O)-476.4(w)0(e)18.8(r)0(e)-481.4(n)0(o)20.8(t)-490.8(in)20.7(te)19.5(rv)20.9(ie)19.5(we)18.8(d)-490.7(f)0(u)20.9(r)0(t)20.7(h)0(e)19.7(r)0(.)-482.6(T)0(h)19.6(i)0(s)-474.4(m)0(a)18.4(d)0(e)]TJ
ET
q
1 i
60.321 732.245 m
298.261 732.245 l
298.261 473.272 l
60.321 473.272 l
W n
q
238.023 0 0 258.973 60.321 473.272 cm
/Im1 Do
Q
Q
BT
/F6 1 Tf
9.845 0 0 9.845 59.7543 456.4912 Tm
[(FIG.)-336.7(1.)]TJ
/F5 1 Tf
4.1174 0 TD
[(Proportion)-338.3(\(%\))-338(of)-336(patients)-333.1(included)-338.8(from)-339.1(the)-332.6(dif-)]TJ
-4.1174 -1.0135 TD
[(ferent)-342.5(settings)-337.5(of)-341.7(care)-341.5(in)-336.2(the)-338.3(nine)-339.3(participating)-339.7(countries)-339.7(of)]TJ
0 -1.0077 TD
[(the)-338.3(LIMPRINT)-335.2(Study.)]TJ
ET
59.754 223.427 490.167 .22675 re
f
59.754 86.343 490.167 .22675 re
f
59.754 174.841 490.167 .22676 re
f
BT
/F8 1 Tf
9.845 0 0 9.845 88.3842 229.096 Tm
(Table)Tj
/F5 1 Tf
3.0002 0 TD
(1.)Tj
/F8 1 Tf
1.2496 0 TD
[(Point)-334.2(Prevalence)-333(of)-337(Chronic)-332.7(Edema)-335(in)-331.6(the)-338.1(Seven)-334(Acute)-329.4(Hospital)-337.8(Inpatient)-334.9(Facilities)]TJ
/F10 1 Tf
-7.1579 -4.8775 TD
(Facility)Tj
14.5634 1.0077 TD
[(Patients)-333.1(with)]TJ
1.2323 -1.0077 TD
[(CO)-332(\()]TJ
/F5 1 Tf
2.05 0 TD
(n)Tj
/F10 1 Tf
.501 0 TD
(\))Tj
4.8141 2.0212 TD
[(Patients)-338.9(clinically)]TJ
1.4108 -1.0135 TD
[(assessed)-337.8(in)]TJ
.311 -1.0077 TD
[(wards)-333.8(\()]TJ
/F5 1 Tf
3.1039 0 TD
(n)Tj
/F10 1 Tf
.4952 0 TD
(\))Tj
6.6684 3.0347 TD
(Prevalence)Tj
.4549 -1.0135 TD
[(of)-336.2(CO)-332(in)]TJ
-1.8197 -1.0135 TD
[(patients)-331.9(clinically)]TJ
.9905 -1.0077 TD
[(assessed)-337.8(\(%\))]TJ
9.5131 3.0347 TD
[(Total)-333.4(number)]TJ
1.2784 -1.0135 TD
[(of)-330.4(beds)]TJ
-.6968 -1.0135 TD
[(in)-330.4(hospital)]TJ
1.5836 -1.0077 TD
(\()Tj
/F5 1 Tf
.334 0 TD
(n)Tj
/F10 1 Tf
.501 0 TD
(\))Tj
/F5 1 Tf
-47.2892 -1.9003 TD
[(Montpellier,)-340.6(F)-10608.1(215)-8191.6(726)-8859.6(29.6)-7751.6(1150)]TJ
0 -1.0135 TD
[(Canberra,)-338.3(AU)-11290.4(31)-8190.6(113)-8859.6(27.4)-8252.6(113)]TJ
0 -1.0077 TD
[(Ireland)-14647.7(5)-8690.6(4)0(5)-8858.6(11.1)-8753.6(62)]TJ
0 -1.0135 TD
[(QMC,)-337.2(UK)-12194.5(155)-8191.6(324)-8859.6(47.8)-8252.6(634)]TJ
T*
[(City)-339.3(Hospital,)-330.4(UK)-9010(140)-8191.6(245)-8859.6(57.1)-8252.6(490)]TJ
0 -1.0077 TD
[(Bispebjerg)-341.7(Hospital,)-336.1(DK)-6389.9(134)-8191.6(326)]TJ
7.3837 0 0 6.5625 332.2771 116.9575 Tm
(a)Tj
9.845 0 0 9.845 419.4708 112.5921 Tm
[(41.1)-8252.6(437)]TJ
-36.538 -1.0135 TD
[(Frederiksberg)-338.7(Hospital,)-336.1(DK)-5675.8(43)-8190.6(126)]TJ
7.3837 0 0 6.5625 332.2771 106.9795 Tm
(a)Tj
9.845 0 0 9.845 419.4708 102.6141 Tm
[(34.1)-8252.6(141)]TJ
-36.538 -1.0135 TD
[(Total)-14363.7(723)-7696.4(1905)-8854.8(38.0)-7751.6(3041)]TJ
8.7511 0 0 8.7511 67.748 74.4944 Tm
-.0205 Tc
[(Only)-220.2(patients)-218.6(under)-218.7(t)1.4(he)-221.3(Oncology)-220.2(Service)-221.3(\()1.5(45/62)-220.2(pati)-5.1(ents\))-218.7(w)-2.2(ere)-214.9(a)-1.1(ssessed)-213.7(f)]TJ
28.2197 0 TD
-.0201 Tc
[(or)-211.8(swelli)-4.7(ng)-213.3(at)-218.5(the)-214.5(U)-1.8(ni)-4.7(versi)-4.7(t)1.8(y)-213.3(H)-1.8(ospital)-218.5(G)-1.8(alway)-213.3(\()1.9(t)-4.7(o).5(tal)-218.5(b).5(ed)-213.3(capaci)-4.7(ty)-213.3(708\).)]TJ
6.5633 0 0 5.8334 67.748 69.4488 Tm
0 Tc
(a)Tj
8.7511 0 0 8.7511 70.696 65.537 Tm
[(Patients)-330.8(were)-335.4(assessed)-337.6(in)-333.3(these)-330.5(two)-334.4(hospitals.)]TJ
-.3369 -1.0236 TD
[(CO,)-335.4(chronic)-328.4(edema.)]TJ
/F3 1 Tf
8.9663 0 0 8.9663 59.7543 749.7069 Tm
[(PREVALENCE)-341.6(OF)-331.2(CHRONIC)-336.8(OEDEMA)-334.9(IN)-335.1(HOSPITALS)-27363.8(137)]TJ
ET
endstream
endobj
37 0 obj
<>stream
Adobe d C
s !1AQa"q2B#R3b$r%C4Scs5D'6Tdt&
EFVU(eufv7GWgw8HXhx)9IYiy*:JZjz ? Nlٳf͛6lٳf͛6lٳf͛1 Ir;~bD
WF\( *9ޭ"Y?|9.E/0tOԾ70>d~rR1t4 % ו2P-)4_pIGp+mUUbȕ:y[Z}{w,RD!Ӗ~"/sa0 kBd+o_>FG T<~wg 9E0`/x{{c Kɟ$Nic3D/ΰ%O嶪ByHh=97Oђ.mԂTGF>f͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛65-?N{B+;XdwXQ@O/}$`MN6*9??*1ɤ[YhxSu8))g5?06_+}^EфI)#U͛6 ?㫧eL i2eYCq_iw\}.}:e5i+kD dDҸ#j&ޝ@-zDދ7ǥO?F?Z%@YWS<8=}SQ,N:#3f͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6li0jTV( <8@
jɚzߨv ̟qM^aֵNT}rԌR4 b]6^VlٰN ];c-g} K P 3͕6\L%ͻfB}lU*f܁L7?Ώ#mQ}H'6 ?طѓٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳa/)魨PWsY$#bUݽg?0 (Ǭ,|hqF`{ E~gKɤkݥNf͛6lٳ`7:w[ 9/ ) l Q/+/+/+/6P 嗉t *o%~oʬvum%~p63|OzȟPki͎OKLikQMf͛6lٳf͛6lٳf͛6lٳf͛6l٦ic5-$B$8
I*z*RV xyYusQ}OZQ$ٮn>/* yf͛6lٳfou r_S/C_9FVlٳeW4BVXlWھ8OhV %70CUA"Ǯ\>M55-;GشgF<W
3f͛6lٳf͛6lٳf͛6lٳf͛#x